当前位置: X-MOL 学术Drug Des. Dev. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Structural Insight into the Mechanism of 4-Aminoquinolines Selectivity for the alpha2A-Adrenoceptor.
Drug Design, Development and Therapy ( IF 4.8 ) Pub Date : 2020-07-03 , DOI: 10.2147/dddt.s214157
Zaibing Li 1, 2 , Jingyu Li 1 , Liyan Liu 1 , Wenyi Deng 3 , Qingrong Liu 4 , Ruofan Liu 4 , Wen Zhang 3 , Zaiqing He 5 , Lei Fan 6 , Yingzhuo Yang 7 , Yun Duan 7 , Huifang Hou 1 , Xinyuan Wang 1 , Zhimei Yang 1 , Xiaoying Wang 1 , Shanze Chen 1 , Yi Wang 1 , Ning Huang 1 , Junli Chen 1
Affiliation  

Background: α2A-adrenoceptor (AR) is a potential target for the treatment of degenerative diseases of the central nervous system, and α2A-AR agonists are effective drugs for this condition. However, the lack of high selectivity for α2A-AR subtype of traditional drugs greatly limits their clinic usage.
Methods: A series of homobivalent 4-aminoquinolines conjugated by two 4-aminoquinoline moieties via varying alkane linker length (C2-C12) were characterized for their affinities for each α2-AR subtype. Subsequently, docking, molecular dynamics and mutagenesis were applied to uncover the molecular mechanism.
Results: Most 4-aminoquinolines (4-aminoquinoline monomer, C2-C6, C8-C10) were selective for α2A-AR over α2B- and α2C-ARs. Besides, the affinities are of similar linker length-dependence for each α2-AR subtype. Among all the compounds tested, C10 has the highest affinity for α2A-AR (pKi=− 7.45± 0.62), which is 12-fold and 60-fold selective over α2B-AR and α2C-AR, respectively. Docking and molecular dynamics suggest that C10 simultaneously interacts with orthosteric and “allosteric” sites of the α2A-AR. The mutation of F205 decreases the affinity by 2-fold. The potential allosteric residues include S90, N93, E94 and W99.
Conclusion: The specificity of C10 for the α2A-AR and the potential orthosteric and allosteric binding sites proposed in this study provide valuable guidance for the development of novel α2A-AR subtype selective compounds.



中文翻译:

对 alpha2A-肾上腺素受体的 4-氨基喹啉选择性机制的结构洞察。

背景: α2A-肾上腺素能受体(AR)是治疗中枢神经系统退行性疾病的潜在靶点,α2A -AR激动剂是治疗该病的有效药物。然而,传统药物α 2A -AR 亚型缺乏高选择性,极大地限制了其临床应用。
方法:通过不同的烷烃接头长度 (C2-C12) 对一系列由两个 4-氨基喹啉部分缀合的同二价 4-氨基喹啉进行表征,以确定它们对每个 α 2 -AR 亚型的亲和力。随后,应用对接、分子动力学和诱变技术揭示了分子机制。
结果:大多数 4-氨基喹啉(4-氨基喹啉单体,C2-C6,C8-C10)对 α 2A -AR 的选择性高于对 α 2B - 和 α 2C -ARs 的选择性。此外,对于每个 α 2 -AR 亚型,亲和力具有相似的接头长度依赖性。在所有测试的化合物中,C10 对 α 2A -AR 的亲和力最高(p Ki=- 7.45± 0.62),其选择性分别是 α 2B -AR 和 α 2C -AR的 12 倍和 60 倍。对接和分子动力学表明 C10 同时与 α 2A的正构和“变构”位点相互作用-AR。F205 的突变使亲和力降低了 2 倍。潜在的变构残基包括 S90、N93、E94 和 W99。
结论: C10 对α 2A -AR 的特异性以及本研究提出的潜在正构和变构结合位点为开发新型α 2A -AR 亚型选择性化合物提供了有价值的指导。

更新日期:2020-07-03
down
wechat
bug